RANDOMIZATION
Our team has extensive experience developing complex randomization schemes, including dynamic allocation (adaptive randomization).
Prancer supports central randomization, site blocked randomization, multiple strata, dynamically blocked to strata, dynamically blocked to strata and site as well as multiple randomizations.
Within the past few years, the conversation has shifted from deciding between paper or electronic TMF solutions to instead solidifying what features are required to make an eTMF solution the most optimal. Technology is evolving—and while the life sciences industry has a reputation for being slow to adopt tech advancements in clinical research, it’s catching on to innovations in eTMF pretty quickly.
Clinical trials mobile application for us in early phase and Phase I research.
mSource is Medrio's mobile eSource application that includes mPRO, mCapture, and mConsent. All products are native applications and are designed for use in early phase and Phase I research.
mEDU is CFR Part 11 compliant software with CloudEDC™ that is FREE for investigator initiated trials.
m1 is Medrio's eClinical suite for Phase I including CloudEDC™ and all the features you need to make your Phase I trial run smoothly.
mCore is Medrio's all Phase eClinical suite which includes CloudEDC™. It is well suited for Phase II, III, IV, in Pharma, Diagnostics, Medical Device, and Animal Health studies.
mSource is Medrio's mobile eSource application that includes mPRO, mCapture, and mConsent. All products are native applications and are designed for use in early phase and Phase I research.
Time and again, when we ask our partners in clinical development roles what their number one concern is, they respond that recruiting clinical trial patients and sites on-time and on-budget is an enormous and expensive challenge.
If making payments to clinical research sites is a constant headache, it’s time to quit using legacy technology.
|
|
|
|
|
|
|
|
|